EP12.01. First-line Aumolertinib Treatment in Non-Small Cell Lung Cancer (NSCLC) with Primary EGFR T790M Mutation: A Report of two Cases - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Li Zang
Meta Tag
Speaker Li Zang
Topic Metastatic NSCLC: Targeted Therapy - EGFR/HER2
World Conference on Lung Cancer
case report
EGFR T790M mutation
aumolertinib monotherapy
partial response
disease progression
genetic testing
sustained disease control
targeted therapy
Powered By